BRIEF published on 07/08/2025 at 22:15, 11 months 28 days ago GENFIT annonce son contrat de liquidité semestriel avec le Crédit Industriel et Commercial Biopharmaceutique Crédit Industriel Maladies Du Foie Liquidité De GENFIT Négociations 2025
PRESS RELEASE published on 07/08/2025 at 22:10, 11 months 28 days ago Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial GENFIT announces half-year report of liquidity contract with Crédit Industriel et Commercial, detailing trading activities and resources as of June 30, 2025 Liquidity Contract Financial Report Crédit Industriel Et Commercial Trading Activities GENFIT
PRESS RELEASE published on 07/08/2025 at 22:10, 11 months 28 days ago Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial GENFIT annonce le bilan semestriel de son contrat de liquidité avec le Crédit Industriel et Commercial, incluant les transactions et moyens de liquidité au 30 juin 2025 Contrat De Liquidité Bilan Semestriel Transactions Crédit Industriel Et Commercial GENFIT
BRIEF published on 06/17/2025 at 20:35, 1 year ago L'Assemblée Générale de GENFIT approuve les résolutions du Conseil d'Administration Resolutions Produits Biopharmaceutiques Assemblée Générale Des Actionnaires GENFIT Maladies Du Foie
BRIEF published on 06/17/2025 at 20:35, 1 year ago GENFIT's Shareholder Meeting Approves Board's Resolutions Biopharmaceuticals Resolutions Liver Diseases Shareholders Meeting GENFIT
PRESS RELEASE published on 06/17/2025 at 20:30, 1 year ago GENFIT: June 17, 2025 Combined Shareholders Meeting Results GENFIT announces approval of all resolutions at June 17, 2025 Combined Shareholders Meeting. Exception: resolution n°28 rejected. Quorum: 27.21% Resolutions Approval Quorum Shareholders Meeting GENFIT
PRESS RELEASE published on 06/17/2025 at 20:30, 1 year ago GENFIT : Résultats de l’Assemblée Générale Mixte du 17 juin 2025 GENFIT annonce les résultats de son Assemblée Générale Mixte du 17 juin 2025, approuvés avec un quorum de 27,21%, tout en dévoilant sa mission et activités dans le secteur biopharmaceutique Biopharmaceutique Assemblée Générale Mixte Maladies Rares GENFIT Foie
BRIEF published on 05/22/2025 at 22:15, 1 year 1 month ago GENFIT: First Quarter 2025 Financial Results Treasury Royalties GENFIT Iqirvo® Clinical Phase
BRIEF published on 05/22/2025 at 22:15, 1 year 1 month ago GENFIT : Résultats financiers du premier trimestre 2025 Trésorerie Royalties GENFIT Iqirvo® Phase Clinique
PRESS RELEASE published on 05/22/2025 at 22:10, 1 year 1 month ago GENFIT Reports First Quarter 2025 Financial Information GENFIT reports Q1 2025 financial information showing cash position growth and revenue increase. Details on Royalty Financing agreement, research efforts, and corporate governance update included Financial Information Revenue Cash Position GENFIT Q1 2025
Published on 07/06/2026 at 02:25, 3 hours 23 minutes ago Tunkillia Infill Drilling Delivers More High-Grade Assays
Published on 07/03/2026 at 23:00, 2 days 6 hours ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 2 days 8 hours ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 2 days 10 hours ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/06/2026 at 02:33, 3 hours 14 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Portfolio valuations update
Published on 07/05/2026 at 13:45, 16 hours 2 minutes ago XPPen renforce son engagement en faveur de l’animation grâce à son partenariat avec la Résidence du Festival d’Annecy 2026 et sa présence au MIFA
Published on 07/05/2026 at 13:45, 16 hours 2 minutes ago XPPen Strengthens Its Commitment to Animation with 2026 Annecy Festival Residency Partnership and MIFA Showcase
Published on 07/04/2026 at 17:35, 1 day 12 hours ago Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/03/2026 at 21:49, 2 days 7 hours ago Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 2 days 7 hours ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 2 days 11 hours ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 2 days 11 hours ago Disclosure of transactions in own shares from July 1 to July 3, 2026
